Heart failure due to ischemic cardiomyopathy Circulatory System Ischaemic cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from heart failure symptoms with cardiac dysfunction caused by a previous myocardial infarction resulting in increased ventricular volume and anteroseptal or apical scar Additional general inclusion criteria: 2. Subject is >18 years of age 3. Subject is able and willing to provide written informed consent 4. Subject is on guideline directed medical therapy (GDMT) for heart failure
Exclusion criteria
Exclusion criteria: 1. Inadequate myocardial viability in regions remote from the scar 2. Thrombus or intra-ventricular mass 3. Cardiac Resynchronization Therapy (CRT) 4. Patient intolerance or unwillingness to take anti-coagulation medication 5. Functioning pacemaker leads in antero-apical RV 6. Pulmonary Arterial Pressure > 60 mm Hg 7. Myocardial Infarction less than 90 days before the procedure 8. Previous right neck surgery, previous pericardiotomy, previous left chest surgery that precludes device placement 9. Chronic renal failure with a serum creatinine >2 mg/dL 10. Inoperable coronary disease with significant ischemia 11. Pulmonary disease that would preclude transient single lung ventilation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in Left Ventricular volume is measured using echocardiography at 6 months, 1, 2, 3, 4 and 5 years. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in heart failure status assessed by Left Ventricular Ejection Fraction, New York Heart Association class, quality of life assessment, and walking distance as measured by a 6-minute walk exam at baseline, 6 months, 1, 2, 3, 4 and 5 years. | — |
Countries
Czech Republic, Germany, Italy, Switzerland